Cargando…

Additional insights on COVID-associated mucormycosis

Detalles Bibliográficos
Autor principal:	Panta, Prashanth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591849/ https://www.ncbi.nlm.nih.gov/pubmed/35120786 http://dx.doi.org/10.1016/j.bjoms.2021.09.020

Ejemplares similares

Mucormycosis Following COVID-19 Infections: an Insight
por: Das, Srijit, et al.
Publicado: (2021)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

The surge in Covid related mucormycosis
por: Chandra, Somesh, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

A toddler infected with mucormycosis – reporting the youngest case of mucormycosis in post COVID phase
por: Kubre, Jyotsna, et al.
Publicado: (2023)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Comment to: “Association of COVID-19 with Rhino-Cerebral Mucormycosis: An Observational Study”
por: Vaidyanathan, Aiswarya, et al.
Publicado: (2022)

COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021)

Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors
por: Arakeri, Gururaj, et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis and Anbarnesa: Concerning about Important Source of Spores
por: Pourazizi, Mohsen, et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis: Ramping up our services during crisis
por: Xess, Immaculata, et al.
Publicado: (2022)

Palliative oral care for COVID-19 associated oral mucormycosis in diabetic patients
por: Rathee, Manu, et al.
Publicado: (2022)

Post-COVID mucormycosis: Ascertainment of the pathological diagnostic approach
por: Sood, Anubhuti, et al.
Publicado: (2021)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
por: Tandon, Abhishek, et al.
Publicado: (2021)

Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

COVID 19 infection and mucormycosis—a dangerously increasing combination
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023)

Mucormycosis masquerading as an endobronchial tumor
por: Mahajan, Rajesh, et al.
Publicado: (2014)

Role of medial orbital wall decompression in COVID-19-associated rhino-orbital mucormycosis management
por: Murthy, Ramesh, et al.
Publicado: (2021)

Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021)

COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy
por: Bhardwaj, Ankit, et al.
Publicado: (2021)

Knowledge and awareness of COVID-19–associated mucormycosis among doctors in a tertiary care center
por: Shaikh, Zeba Muzammil, et al.
Publicado: (2023)

Preliminary Planning for Mucormycosis in Developing Countries During COVID-19 Pandemic
por: Shakrawal, Neha, et al.
Publicado: (2021)

Gastrointestinal mucormycosis post lung transplantation
por: Reis, Flavio Pola dos, et al.
Publicado: (2019)

Additional Insights into the REPLICA-PH Study
por: Karamsi, Ashok Kumar
Publicado: (2023)

COVID-19 associated mucormycosis: a life-threatening complication in patients admitted with severe to critical COVID-19 from Pakistan
por: Nasir, Nosheen, et al.
Publicado: (2021)

Unusual cause of difficult mask ventilation in patients of mucormycosis – Another challenge in the Covid era
por: Aneejwal, Himanshu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8mv0fg8kbdh3s0j3f59h6v0rv